Conditional settlement reached with Purdue over opioid crisis in US
A US federal bankruptcy judge gave conditional approval to a settlement that will remove the Sackler family from ownership of OxyContin maker Purdue Pharma and devote potentially 10 billion US dollars to fighting the opioid crisis that has killed half a million Americans over the past two decades.
If it withstands appeals, the deal will resolve a mountain of 3,000 lawsuits from US state and local governments, Native American tribes, unions and others that accuse the company of helping to spark the overdose epidemic by aggressively marketing the prescription painkiller.
